# Notch signaling activation reduces vesicular endocytosis in human pluripotent stem cell-derived CNS-like endothelial cells

**Authors:** Sarah M. Boutom, Luke D. Walsh, Maxwell M. Herman, Yunfeng Ding, Fatemeh Yaghoobi Hashjin, Benjamin K. August, Eric V. Shusta, Sean P. Palecek

PMC · DOI: 10.1186/s12987-025-00754-6 · Fluids and Barriers of the CNS · 2026-01-16

## TL;DR

This study shows that Notch signaling lowers vesicular endocytosis in human brain-like endothelial cells, helping to understand how the blood-brain barrier forms.

## Contribution

The study demonstrates that Notch signaling reduces vesicular endocytosis in a human in vitro model of the blood-brain barrier.

## Key findings

- N1ICD overexpression upregulated GLUT-1 and reduced PLVAP and caveolin-1 expression.
- Combined Wnt/β-catenin activation and N1ICD overexpression reduced vesicles and albumin uptake.
- Notch signaling contributes to reduced transcytosis in human CNS-like endothelial cells.

## Abstract

Mechanisms guiding the induction of blood-brain barrier (BBB) properties in central nervous system (CNS) endothelial cells during human development are incompletely understood. For example, there is a limited understanding of signaling pathways that influence the unique property of low vesicular endocytosis and transcytosis in brain microvascular endothelial cells (BMECs) relative to peripheral endothelial cells. Mouse studies suggest the importance of BBB-relevant developmental pathways, including Wnt and Notch signaling, for the induction of this BBB feature in developing BMECs.

To explore induction of reduced vesicular endocytosis and transcytosis in human in vitro model of the BBB, we used human pluripotent stem cell (hPSC)-derived endothelial progenitor cells (EPCs) in which Wnt/β-catenin signaling was activated to generate hPSC-derived CNS-like ECs (hPSC-CECs). We assessed the effects of Notch signaling through overexpression of the Notch1 receptor intracellular domain (N1ICD).

N1ICD overexpression in hPSC-CECs resulted in upregulation of GLUT-1, a BBB-enriched glucose transporter, and decreased expression of both PLVAP and caveolin-1, two vesicular endocytosis-associated proteins. The combination of Wnt/β-catenin activation and N1ICD overexpression resulted in fewer vesicles and reduced albumin uptake.

These findings indicate that Notch signaling reduces vesicular endocytosis and transcytosis in a human model of the developing BBB and contribute to our understanding of how Notch signaling induces these specific BBB properties in this model of human CNS EC development.

The online version contains supplementary material available at 10.1186/s12987-025-00754-6.

## Linked entities

- **Genes:** SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513], PLVAP (plasmalemma vesicle associated protein) [NCBI Gene 83483], CAV1 (caveolin 1) [NCBI Gene 373996], NOTCH1 (notch receptor 1) [NCBI Gene 4851], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441]
- **Proteins:** SLC2A1 (solute carrier family 2 member 1), PLVAP (plasmalemma vesicle associated protein), CAV1 (caveolin 1), NOTCH1 (notch receptor 1)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CLTC (clathrin heavy chain) [NCBI Gene 1213] {aka CHC, CHC17, CLH-17, CLTCL2, Hc, MRD56}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363] {aka ABC29, ABCC, DFNA77, GS-X, MRP, MRP1}, SLC7A2 (solute carrier family 7 member 2) [NCBI Gene 6542] {aka ATRC2, CAT-2A, CAT-2B, CAT2, HCAT2, SLC7A2A}, NOTCH3 (notch receptor 3) [NCBI Gene 4854] {aka CADASIL, CADASIL1, CARASIL1, CASIL, FPLD1, IMF2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TREH (trehalase) [NCBI Gene 11181] {aka TRE, TREA, TREHD}, HEY (hairy ears, Y-linked) [NCBI Gene 100188776], JAG1 (jagged canonical Notch ligand 1) [NCBI Gene 182] {aka AGS, AGS1, AHD, AWS, CD339, CMT2HH}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, DLL1 (delta like canonical Notch ligand 1) [NCBI Gene 28514] {aka DELTA1, DL1, Delta, NEDBAS}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, ETV2 (ETS variant transcription factor 2) [NCBI Gene 2116] {aka ER71, ETSRP71}, LSR (lipolysis stimulated lipoprotein receptor) [NCBI Gene 51599] {aka ILDR3, LISCH7}, SLC7A1 (solute carrier family 7 member 1) [NCBI Gene 6541] {aka ATRC1, CAT-1, ERR, HCAT1, REC1L}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, RRBP1 (ribosome binding protein 1) [NCBI Gene 6238] {aka ES/130, ES130, RRp, hES, p180}, APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) [NCBI Gene 26060] {aka APPL, DIP13alpha, MODY14}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}, RBPJ (recombination signal binding protein for immunoglobulin kappa J region) [NCBI Gene 3516] {aka AOS3, CBF-1, CBF1, IGKJRB, IGKJRB1, KBF2}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, CLDN3 (claudin 3) [NCBI Gene 1365] {aka C7orf1, CPE-R2, CPETR2, HRVP1, RVP1}, CLTA (clathrin light chain A) [NCBI Gene 1211] {aka LCA}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 6515] {aka GLUT3}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, CNN1 (calponin 1) [NCBI Gene 1264] {aka HEL-S-14, SMCC, Sm-Calp}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, JAG2 (jagged canonical Notch ligand 2) [NCBI Gene 3714] {aka HJ2, LGMDR27, SER2}, Cdh5 (cadherin 5) [NCBI Gene 12562] {aka 7B4, Cd144, VE-Cad, VECD, VEcad, Vec}, ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429] {aka ABC15, ABCP, BCRP, BMDP, CD338, CDw338}, HES5 (hes family bHLH transcription factor 5) [NCBI Gene 388585] {aka bHLHb38}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, CSPG4 (chondroitin sulfate proteoglycan 4) [NCBI Gene 1464] {aka CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, HEYL (hes related family bHLH transcription factor with YRPW motif like) [NCBI Gene 26508] {aka HESR3, HEY3, HRT3, bHLHb33}, NOTCH4 (notch receptor 4) [NCBI Gene 4855] {aka INT3}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, MFSD2A (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 84879] {aka HsMFSD2A, MCPH15, MFSD2, NEDMISBA, NLS1, SLC59A1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** Melanoma (MESH:D008545), N1ICD (MESH:D015270), MACS (MESH:D000090362)
- **Chemicals:** CHIR (-), Hygromycin (MESH:C026273), DOX (MESH:D004317), AF647 (MESH:C569686), tetracycline (MESH:D013752), glycine (MESH:D005998), CHIR99021 (MESH:C473711), TRIzol (MESH:C411644), CA (MESH:D002118), ampicillin (MESH:D000667), lipid (MESH:D008055), phenol red (MESH:D010637), Glutaraldehyde (MESH:D005976), CPZ (MESH:D002746), methanol (MESH:D000432), DAPI (MESH:C007293), GlutaMAX (MESH:C054122), Bicinchoninic acid (MESH:C047117), Mg (MESH:D008274), GA (MESH:D005708), agarose (MESH:D012685), CO2 (MESH:D002245), PBS (MESH:D007854), Doxycycline (MESH:D004318), epoxy (MESH:D004853), Dextran (MESH:D003911), silver (MESH:D012834), saponin (MESH:D012503), SYBR Green (MESH:C098022), MbetaCD (MESH:C108732), Y-27632 (MESH:C108830), hygromycin B (MESH:D006921), water (MESH:D014867), Phosphate (MESH:D010710), Tween 20 (MESH:D011136), L-ascorbic acid 2-phosphate magnesium (MESH:C011669), phosphotyrosine (MESH:D019000), Triton X-100 (MESH:D017830), Paraformaldehyde (MESH:C003043), osmium tetroxide (MESH:D009993), DMSO (MESH:D004121), Hoechst 33342 (MESH:C017807), EDTA (MESH:D004492), ethanol (MESH:D000431), rottlerin (MESH:C085746), F-12 (MESH:C007782), DPBS (MESH:C012939), acetic acid (MESH:D019342), FITC (MESH:D016650), uranyl acetate (MESH:C005460)
- **Species:** Lentivirus (genus) [taxon 11646], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** S12F, T2A
- **Cell lines:** TransIT-LT1 — Homo sapiens (Human), Lung lymphangioleiomyomatosis, Finite cell line (CVCL_8891), -N1ICD — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TA87), E8 — Mus musculus (Mouse), Transformed cell line (CVCL_C4KE), PB — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_RQ10), hPSC — Gallus gallus (Chicken), Induced pluripotent stem cell (CVCL_YE48), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), IMR90-4 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_C437), hCMEC.D3 — Homo sapiens (Human), Transformed cell line (CVCL_U985), HBMEC — Bos taurus (Bovine), Transformed cell line (CVCL_A1BE), 293TN — Homo sapiens (Human), Transformed cell line (CVCL_UL49), Haortic — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U411)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12874909/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12874909/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12874909/full.md

---
Source: https://tomesphere.com/paper/PMC12874909